rs754608173
Positions:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_016156.6(MTMR2):c.1770+7_1770+12delGCCTTA variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00051 in 1,590,992 control chromosomes in the GnomAD database, including 5 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0029 ( 4 hom., cov: 32)
Exomes 𝑓: 0.00026 ( 1 hom. )
Consequence
MTMR2
NM_016156.6 splice_region, intron
NM_016156.6 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.241
Genes affected
MTMR2 (HGNC:7450): (myotubularin related protein 2) This gene is a member of the myotubularin family of phosphoinositide lipid phosphatases. The encoded protein possesses phosphatase activity towards phosphatidylinositol-3-phosphate and phosphatidylinositol-3,5-bisphosphate. Mutations in this gene are a cause of Charcot-Marie-Tooth disease type 4B, an autosomal recessive demyelinating neuropathy. Alternatively spliced transcript variants encoding multiple isoforms have been found for this gene. [provided by RefSeq, Aug 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 11-95836135-GTAAGGC-G is Benign according to our data. Variant chr11-95836135-GTAAGGC-G is described in ClinVar as [Benign]. Clinvar id is 543499.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr11-95836135-GTAAGGC-G is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00295 (442/149856) while in subpopulation AFR AF= 0.0102 (424/41422). AF 95% confidence interval is 0.00943. There are 4 homozygotes in gnomad4. There are 202 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTMR2 | NM_016156.6 | c.1770+7_1770+12delGCCTTA | splice_region_variant, intron_variant | ENST00000346299.10 | NP_057240.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTMR2 | ENST00000346299.10 | c.1770+7_1770+12delGCCTTA | splice_region_variant, intron_variant | 1 | NM_016156.6 | ENSP00000345752.6 |
Frequencies
GnomAD3 genomes AF: 0.00295 AC: 442AN: 149738Hom.: 4 Cov.: 32
GnomAD3 genomes
AF:
AC:
442
AN:
149738
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000256 AC: 369AN: 1441136Hom.: 1 AF XY: 0.000204 AC XY: 146AN XY: 717254
GnomAD4 exome
AF:
AC:
369
AN:
1441136
Hom.:
AF XY:
AC XY:
146
AN XY:
717254
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00295 AC: 442AN: 149856Hom.: 4 Cov.: 32 AF XY: 0.00276 AC XY: 202AN XY: 73136
GnomAD4 genome
AF:
AC:
442
AN:
149856
Hom.:
Cov.:
32
AF XY:
AC XY:
202
AN XY:
73136
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
MTMR2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 02, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Charcot-Marie-Tooth disease type 4 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 04, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at